Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 5/2013

01-09-2013 | Original Article

Health-related quality of life in children and adolescents with phenylketonuria: unimpaired HRQoL in patients but feared school failure in parents

Authors: Eva Thimm, Lisa Elena Schmidt, Katrin Heldt, Ute Spiekerkoetter

Published in: Journal of Inherited Metabolic Disease | Issue 5/2013

Login to get access

Abstract

Aim of the study was the evaluation of health-related quality of life (HRQoL) and the detection of deviant behavior in early-treated children and adolescents with PKU in comparison with healthy peers. Special focus was laid on the impact of compliance with treatment as defined by the national recommendations on HRQoL. Our investigation in 50 children and adolescents and their parents for the first time demonstrates that despite an overall normal HRQoL in our PKU patient collective, parents are concerned about performance in school especially when phenylalanine concentrations in their children are mainly above the therapeutic range. Adherence to target phenylalanine concentrations ameliorated markedly in patients above 10 years in comparison to younger patients due to relaxed treatment recommendations. Interestingly, this alleged improvement in metabolic control has an impact on the parent assessed but not on the patient assessed appraisal of HRQoL. However, a positive correlation between poor metabolic control and conduct problems was identified by patients’ self-assessment. In conclusion, lacking adherence to the strict treatment recommendations in infancy results in significant concern about school success and success in life in parents of PKU patients. With relaxation of dietary phenylalanine restriction at 10 years of age, these concerns diminish.
Literature
go back to reference Anjema K, van Rijn M, Verkerk PH, Burgerhof JG, Heiner-Fokkema MR, van Spronsen FJ (2011) PKU: high plasma phenylalanine concentrations are associated with increased prevalence of mood swings. Mol Genet Metab 104:231–234CrossRefPubMed Anjema K, van Rijn M, Verkerk PH, Burgerhof JG, Heiner-Fokkema MR, van Spronsen FJ (2011) PKU: high plasma phenylalanine concentrations are associated with increased prevalence of mood swings. Mol Genet Metab 104:231–234CrossRefPubMed
go back to reference Bik-Multanowaki M, Didycz B, Mozrzymas R et al (2008) Quality of life in noncompliant adults with phenylketonuria after resumption of the diet. J Inherit Metab Dis Short Report # 133 Bik-Multanowaki M, Didycz B, Mozrzymas R et al (2008) Quality of life in noncompliant adults with phenylketonuria after resumption of the diet. J Inherit Metab Dis Short Report # 133
go back to reference Bosch AM, Tybout W, van Spronsen FJ, de Valk HW, Wijburg FA, Grootenhuis MA (2007) The course of life and quality of life in early and continuously treated Dutch patients with phenylketonuria. J Inherit Metab Dis 30:29–34CrossRefPubMed Bosch AM, Tybout W, van Spronsen FJ, de Valk HW, Wijburg FA, Grootenhuis MA (2007) The course of life and quality of life in early and continuously treated Dutch patients with phenylketonuria. J Inherit Metab Dis 30:29–34CrossRefPubMed
go back to reference Bremer HJ et al (2008) Therapie von Patienten mit Phenylketonurie. Empfehlungen zu Diagnostik und Therapie. APS Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen Bremer HJ et al (2008) Therapie von Patienten mit Phenylketonurie. Empfehlungen zu Diagnostik und Therapie. APS Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen
go back to reference Brumm VL, Bilder D, Waisbren SE (2010) Psychiatric symptoms and disorders in phenylketonuria. Mol Genet Metab 9:S59–S63CrossRef Brumm VL, Bilder D, Waisbren SE (2010) Psychiatric symptoms and disorders in phenylketonuria. Mol Genet Metab 9:S59–S63CrossRef
go back to reference Bullinger M (1997) Entwicklung und anwendung von instrumenten zur erfassung der lebensqualität. In: Bullinger M (ed) Lebensqualitätsforschung: Bedeutung—anforderung—akzeptanz. Schattauer, Stuttgart, pp 1–6 Bullinger M (1997) Entwicklung und anwendung von instrumenten zur erfassung der lebensqualität. In: Bullinger M (ed) Lebensqualitätsforschung: Bedeutung—anforderung—akzeptanz. Schattauer, Stuttgart, pp 1–6
go back to reference Bullinger M (2000) Lebensqualität—aktueller stand und neuere entwicklungen der internationalen lebensqualitätsforschung. In: Ravens-Sieberer U, Cieza A (eds) Lebensqualität und gesundheitsökonomie in der medizin: Konzepte—methoden—anwendungen. Landsberg, Ecomed, pp 13–24 Bullinger M (2000) Lebensqualität—aktueller stand und neuere entwicklungen der internationalen lebensqualitätsforschung. In: Ravens-Sieberer U, Cieza A (eds) Lebensqualität und gesundheitsökonomie in der medizin: Konzepte—methoden—anwendungen. Landsberg, Ecomed, pp 13–24
go back to reference Bullinger M, von Mackensen S, Kirchberger I (1994) KINDL—ein fragebogen zur erfassung der gesundheitsbezogenen lebensqualität von kindern. Z Gesundheitspsychologie 1:64–77 Bullinger M, von Mackensen S, Kirchberger I (1994) KINDL—ein fragebogen zur erfassung der gesundheitsbezogenen lebensqualität von kindern. Z Gesundheitspsychologie 1:64–77
go back to reference Burgard P (2000) Development of intelligence in early treated phenylketonuria. Eur J Pediatr 159:74–79CrossRef Burgard P (2000) Development of intelligence in early treated phenylketonuria. Eur J Pediatr 159:74–79CrossRef
go back to reference Cotugno G, Nicolo R, Cappelletti S et al (2011) Adherence to diet and quality of life in patients with phenylketonuria. Acta Paediatr 100:1144–1149CrossRefPubMed Cotugno G, Nicolo R, Cappelletti S et al (2011) Adherence to diet and quality of life in patients with phenylketonuria. Acta Paediatr 100:1144–1149CrossRefPubMed
go back to reference Enns GM, Koch R, Brumm V (2010) Suboptimal outcome in patients with PKU treated with early diet alone: revisiting the evidence. Mol Genet Metab 101:99–109CrossRefPubMed Enns GM, Koch R, Brumm V (2010) Suboptimal outcome in patients with PKU treated with early diet alone: revisiting the evidence. Mol Genet Metab 101:99–109CrossRefPubMed
go back to reference Gassio R, Campistol J, Vilaseca MA et al (2003) Do adult patients with phenylketonuria improve their quality of life after introduction of a phenylalanine-restricted diet? Acta Paediatr 92:1474–1478CrossRefPubMed Gassio R, Campistol J, Vilaseca MA et al (2003) Do adult patients with phenylketonuria improve their quality of life after introduction of a phenylalanine-restricted diet? Acta Paediatr 92:1474–1478CrossRefPubMed
go back to reference Gassio R, Fuste E, Lopez-Sala A et al (2005) School performance in early and continuously treated phenylketonuria. Pediatr Neurol 33:267–271CrossRefPubMed Gassio R, Fuste E, Lopez-Sala A et al (2005) School performance in early and continuously treated phenylketonuria. Pediatr Neurol 33:267–271CrossRefPubMed
go back to reference Goodman R (1997) The Strengths and Difficulties Questionnaire: a research note. J Child Psych Psychiatry Allied Discip 38:581–586CrossRef Goodman R (1997) The Strengths and Difficulties Questionnaire: a research note. J Child Psych Psychiatry Allied Discip 38:581–586CrossRef
go back to reference Griffiths P (2000) Neuropsychological approaches to treatment policy in phenylketonuria. Eur J Pediatr 159:82–86CrossRef Griffiths P (2000) Neuropsychological approaches to treatment policy in phenylketonuria. Eur J Pediatr 159:82–86CrossRef
go back to reference Huijbregts SCJ, de Sonneville LMJ, van Spronsen FJ, Licht R, Sergenat JA (2002) The neuropsychological profile of early and continuously treated phenylketonuria: orienting, vigilance and maintainance versus manipulation-functions of working memory. Neurosci Biobehav Rev 26:697–712CrossRefPubMed Huijbregts SCJ, de Sonneville LMJ, van Spronsen FJ, Licht R, Sergenat JA (2002) The neuropsychological profile of early and continuously treated phenylketonuria: orienting, vigilance and maintainance versus manipulation-functions of working memory. Neurosci Biobehav Rev 26:697–712CrossRefPubMed
go back to reference Lambert C, Bonneh A (2004) The impact of galactosemia on quality of life—a pilot study. J Inherit Metab Dis 27:601–608CrossRefPubMed Lambert C, Bonneh A (2004) The impact of galactosemia on quality of life—a pilot study. J Inherit Metab Dis 27:601–608CrossRefPubMed
go back to reference Landolt M, Nuoffer J, Steinmann B, Superti-Fuga A (2002) Quality of life and psychosocial adjustment in children and adolescents with early treated phenylketonuria can be normal. J Pediatr 40:516–521CrossRef Landolt M, Nuoffer J, Steinmann B, Superti-Fuga A (2002) Quality of life and psychosocial adjustment in children and adolescents with early treated phenylketonuria can be normal. J Pediatr 40:516–521CrossRef
go back to reference Mütze U, Roth A, Weigel JF, Beblo S, Baerwald CG, Bührdel P, Kiess W (2011) Transition of young adults with phenylketonuria from pediatric to adult care. J Inherit Metab Dis 34:701–709CrossRefPubMed Mütze U, Roth A, Weigel JF, Beblo S, Baerwald CG, Bührdel P, Kiess W (2011) Transition of young adults with phenylketonuria from pediatric to adult care. J Inherit Metab Dis 34:701–709CrossRefPubMed
go back to reference Radoschewski M (2000) Gesundheitsbezogene lebensqualität—konzepte und Maße. Entwicklungen und Stand im überblick. Bundesgesundheitsbl—Gesundheitsforsch—Gesundheitsschutz 43:165–189CrossRef Radoschewski M (2000) Gesundheitsbezogene lebensqualität—konzepte und Maße. Entwicklungen und Stand im überblick. Bundesgesundheitsbl—Gesundheitsforsch—Gesundheitsschutz 43:165–189CrossRef
go back to reference Ravens Sieberer U, Gosch A, Abel T et al (2001) Quality of life in children and adolescents—a European public health perspective. Soz Praventivmed 46:294–302CrossRefPubMed Ravens Sieberer U, Gosch A, Abel T et al (2001) Quality of life in children and adolescents—a European public health perspective. Soz Praventivmed 46:294–302CrossRefPubMed
go back to reference Ravens-Sieberer U (2003) Der KINDL-R Fragebogen zur Erfassung der gesundheitsbezogenen Lebensqualität bei Kindern und Jugendlichen- revidierte Form. Göttingen Ravens-Sieberer U (2003) Der KINDL-R Fragebogen zur Erfassung der gesundheitsbezogenen Lebensqualität bei Kindern und Jugendlichen- revidierte Form. Göttingen
go back to reference Ravens-Sieberer U, Bullinger M (1998) Assessing health related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res 7:399–407CrossRefPubMed Ravens-Sieberer U, Bullinger M (1998) Assessing health related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res 7:399–407CrossRefPubMed
go back to reference Ravens-Sieberer U, Ellert U, Erhart M (2007) Health-related quality of life of children and adolescents in Germany. Norm data from the German health interview and examination survey (KiGGS). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 50:810–818CrossRef Ravens-Sieberer U, Ellert U, Erhart M (2007) Health-related quality of life of children and adolescents in Germany. Norm data from the German health interview and examination survey (KiGGS). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 50:810–818CrossRef
go back to reference Ravens-Sieberer U et al (2008) Health-related quality of life in children and adolescents in Germany: results of the BELLA study. Eur Child Adolesc Psychiatry 17(Suppl 1):148–156CrossRefPubMed Ravens-Sieberer U et al (2008) Health-related quality of life in children and adolescents in Germany: results of the BELLA study. Eur Child Adolesc Psychiatry 17(Suppl 1):148–156CrossRefPubMed
go back to reference Simon E, Schwarz M, Roos J et al (2008) Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU). Health Qual Life Outcome 6:25CrossRef Simon E, Schwarz M, Roos J et al (2008) Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU). Health Qual Life Outcome 6:25CrossRef
go back to reference Stemerdink BA, Kalverboer AF, van der Meere JJ (2000) Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J Inherit Metab Dis 23:548–562CrossRefPubMed Stemerdink BA, Kalverboer AF, van der Meere JJ (2000) Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J Inherit Metab Dis 23:548–562CrossRefPubMed
go back to reference Ten Hoedt AE, de Sonneville LMJ, Francois B et al (2011) High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled crossover trial. J Inherit Metab Dis 34:165–171CrossRefPubMed Ten Hoedt AE, de Sonneville LMJ, Francois B et al (2011) High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled crossover trial. J Inherit Metab Dis 34:165–171CrossRefPubMed
go back to reference Van Zutphen KH, Packman W, Sporri L et al (2007) Executive functioning in children and adolescents with phenylketonuria. Clin Genet 72:13–18CrossRef Van Zutphen KH, Packman W, Sporri L et al (2007) Executive functioning in children and adolescents with phenylketonuria. Clin Genet 72:13–18CrossRef
go back to reference Walter JH, White FJ, Hall SK et al (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360:55–57CrossRefPubMed Walter JH, White FJ, Hall SK et al (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360:55–57CrossRefPubMed
go back to reference Weglage J, Fünders B, Wilken B, Schubert S, Schmidt E, Burgard P, Ullrich K (1992) Psychosocial and social findings in adolescents with phenylketonuria. Eur J Pediatr 151:522–525CrossRefPubMed Weglage J, Fünders B, Wilken B, Schubert S, Schmidt E, Burgard P, Ullrich K (1992) Psychosocial and social findings in adolescents with phenylketonuria. Eur J Pediatr 151:522–525CrossRefPubMed
go back to reference Weglage J, Fünders B, Wilken B, Schubert D, Ullrich K (1993) School performance and intellectual outcome in adolescents with phenylketonuria. Acta Paediatr 82:582–586CrossRefPubMed Weglage J, Fünders B, Wilken B, Schubert D, Ullrich K (1993) School performance and intellectual outcome in adolescents with phenylketonuria. Acta Paediatr 82:582–586CrossRefPubMed
Metadata
Title
Health-related quality of life in children and adolescents with phenylketonuria: unimpaired HRQoL in patients but feared school failure in parents
Authors
Eva Thimm
Lisa Elena Schmidt
Katrin Heldt
Ute Spiekerkoetter
Publication date
01-09-2013
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 5/2013
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-012-9566-y

Other articles of this Issue 5/2013

Journal of Inherited Metabolic Disease 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.